Details for: ORENCIA
Company: BRISTOL-MYERS SQUIBB CANADA
| DIN | DIN name | Active Ingredient(s) | Strength | Dosage Form | Route of Administration |
|---|---|---|---|---|---|
| 02402475 | ORENCIA | ABATACEPT | 125 MG / ML | SOLUTION | SUBCUTANEOUS |
| 02282097 | ORENCIA | ABATACEPT | 250 MG / VIAL | POWDER FOR SOLUTION | INTRAVENOUS |
Summary Reports
Consumer Information
The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.